
1.56BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US92764N1028
CUSIP
92764N102
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
5.29
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.18
Wall Street Target Price
23.13
EPS Estimate Current Year
-1.01
EPS Estimate Next Year
-2.37
EPS Estimate Current Quarter
-0.7452
EPS Estimate Next Quarter
-0.6228
Most Recent Quarter
-
Revenue TTM
302,799,008
Gross Profit TTM
-111,021,000
EBITDA
-201,320,992
Profit Margin
-61.03%
Return On Assets TTM
-12.47%
Return On Equity TTM
-21.84%
Revenue Per Share TTM
1.941
Qtly Revenue Growth YOY
19582.50%
Diluted Eps TTM
-1.18
Qtly Earnings Growth YOY
58.50%
Trailing PE
0.00
Forward PE
4
Price Sales TTM
5.1612
Price Book MRQ
1.7441
Enterprise Value Revenue
3
Enterprise Value EBITDA
0
965.00
0.00%128.26
0.00%390.94
-2.36%151.52
-2.31%925.70
-1.93%32.39
-1.88%318.32
-1.17%516.11
-1.04%917.00
-0.91%199.30
-0.11%